Ophthalmology — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-25.

Also called: ophtho, eye surgery. A surgical specialty entered through the separate SF Match (not the main NRMP), plus a separate intern year. Organ system: the eye and its adnexa, one organ at extraordinary depth.

The 30-second version

Ophthalmology is the microsurgery of sight, a full surgical specialty built around a single organ, and the rare one that pairs an operating microscope with a mostly outpatient, largely 9-to-5 life. You split your week between clinic (exams, imaging, in-office lasers and injections) and scheduled OR days (cataract, retina, glaucoma, oculoplastics), operating through a microscope on structures measured in fractions of a millimeter where a tremor can cost someone their vision, and then you go home, usually without heavy call. That combination is why ophthalmology is the "O" in the classic ROAD lifestyle acronym (Radiology, Ophthalmology, Anesthesiology, Dermatology): a surgeon's craft and income with a controllable calendar.1 The catch is scope, because you go very deep on one organ, and the gate: it's one of the most competitive specialties in medicine, and it matches through its own separate, earlier process most premeds have never heard of.

Quick dashboard (details and sources below)
Training after med school 4 years total: 1 intern (PGY-1) + 3 ophthalmology (PGY-2–4)
Total from college start ~12 years (4 undergrad + 4 med school + 4 training)
Competitiveness High — rivals dermatology/plastics; matches via the separate SF Match ⟳
Typical full-time pay ~$410,000–$490,000 total comp (surveys); owners/ASC much higher ⟳
Pay range (structure) W-2 employee ~$476k · partner/owner ~$610k · retina ~$700k ⟳
Lifestyle Outpatient, elective surgery, light call — a top-tier lifestyle field
Burnout Among the lowest in medicine — 25.8% against a 41.9% all-physician average (AMA 2025), second-lowest of the rows it names ⟳
% women 28% practicing (AAMC, 2022 data); 42.6% of residents (ACGME, AY2024-25) ⟳
DO / IMG accessibility Among the least open fields (DO seniors ~34% match; IMG ~2% of matched) ⟳

What they actually do

Ophthalmologists are physician-surgeons of the eye and its surrounding structures. They diagnose and manage the whole span of eye disease, from cataract and glaucoma to diabetic and macular retinal disease, corneal disease, strabismus, and eyelid and orbital problems, and they operate, which is what separates them from optometrists (ODs, who are not physicians). The signature operation is cataract surgery: a high-volume, elective, ~15–30-minute microsurgical case, most often performed in a surgeon-owned ambulatory surgery center (ASC) rather than a hospital OR.1 A comprehensive ophthalmologist's day swings from clinic exams and imaging to in-office lasers and injections to scheduled surgical blocks, the same physician following a problem from diagnosis through the OR and back to clinic.

The work rewards two things at once: fine-motor precision under magnification (sub-millimeter maneuvers watched through a microscope) and optics/technology fluency (lasers, advanced imaging like OCT, and a constant stream of new intraocular-lens and device innovation).1 It is also quietly a window into the rest of the body, because the eye is the only place a physician can directly and non-invasively see blood vessels and a cranial nerve (the optic nerve) in a living person, so ophthalmologists routinely catch systemic disease (diabetes, hypertension, autoimmune disease, tumors, raised intracranial pressure) first.1

Representative procedures: phacoemulsification cataract extraction with intraocular-lens (IOL) implantation · LASIK/PRK and other refractive surgery · intravitreal injections (anti-VEGF for macular degeneration/diabetic eye disease) · laser procedures (SLT for glaucoma, panretinal photocoagulation, YAG capsulotomy) · glaucoma surgery including MIGS (minimally invasive glaucoma surgery) · vitreoretinal surgery for detachments · corneal transplantation · strabismus (eye-muscle) surgery · eyelid, orbit, and lacrimal surgery (oculoplastics).12

A week in the life: Unlike shift or inpatient specialties, ophthalmology runs on a scheduled rhythm. Clinic days are dense but predictable, with a high volume of exams, diagnostics, and in-office procedures. OR days are blocked and elective: a cataract surgeon may do a run of efficient cases in an ASC in a morning. Call exists but is comparatively light. True emergencies (globe rupture, retinal detachment, acute angle-closure glaucoma, orbital cellulitis) are real but far less frequent and less physically punishing than surgical or EM call, with retina and oculoplastics carrying the heaviest urgent load.1 There is little to no inpatient service. The result is a surgeon's career you can largely plan your life around.

The training path & time to completion — and the part no premed knows

Here is the single most important thing a premed will not pick up from a generic specialty list: ophthalmology does not match through the main NRMP Match, and it does not use ERAS. It matches through a completely separate, earlier system: the SF Match (San Francisco Matching Program), run in partnership with AUPO (Association of University Professors of Ophthalmology), using its own Central Application Service (CAS).34 Results come out in late January or around February 1, weeks before the NRMP releases the main Match in mid-March.35 If you want ophthalmology, you are effectively running a year ahead of your classmates on a parallel track with its own logistics and fewer safety nets.

And there's a second wrinkle: the intern year is separate too. Ophthalmology is a 4-year pathway, but it is assembled from two separately-secured pieces:

  1. PGY-1 intern year, one broad clinical year (transitional, or a preliminary year in internal medicine, surgery, family medicine, neurology, or EM). This year is not part of the ophthalmology residency itself and historically had to be arranged on its own.3 An ACGME rule effective July 1, 2021 now requires that this PGY-1 be provided either through an "integrated" program (PGY-1 built into the same institution's ophthalmology residency) or a "joint" program (the ophthalmology program formally partners with a preliminary program).3 In the 2025 SF Match, of 123 programs, 56 were integrated and 67 were joint, so if you match at a joint program you must separately secure your PGY-1 spot.6
  2. PGY-2 through PGY-4, three years of ophthalmology residency, the actual clinical and surgical training. This portion is ACGME-accredited.7

Board: the American Board of Ophthalmology (ABO), an ABMS member board. The program attests surgical competence, then comes a Written Qualifying Examination (WQE), then a virtual, case-based Oral Examination. The certificate is valid 10 years and maintained through Continuing Certification.8

Total from the start of college: ~12 years (4 undergrad + 4 med school + 4 training). Add 1–2 years for a fellowship (most are optional; see Subspecialties).

How competitive is it?

Ophthalmology is highly competitive, repeatedly argued to rival dermatology and plastic surgery, and by some measures the most competitive specialty by applicant board scores.91

The 2025 SF Match numbers, from the official AUPO/SF Match General Report:6 ⟳

  • 123 programs, 525 positions offered, 524 filled → 99.8% fill rate (just 1 unfilled spot). This is a field that essentially never has empty seats.
  • 812 applicants submitted a rank list; 524 matched; 288 did not → an overall match rate of ~65%, and an applicant-to-position ratio of ~1.55:1.
  • Match rate by category: US MD seniors 72% (450/624) · US MD graduates 60% · US DO seniors 34% · DO graduates 36% · IMG seniors 0% · IMG graduates 21% (11/52).

Board scores are the highest in medicine. Matched US seniors post a mean Step 2 CK of 258 against 245 for unmatched US seniors, reported as the highest average of any specialty, and now the dominant screening metric since Step 1 went pass/fail.61 27% of matched applicants had AOA status recorded as "Elected," against 5% of unmatched — read that as a floor rather than a share, because the report notes the rest either did not respond, were not yet determined, or came from schools with no AOA chapter.6 The publication counts often quoted for this field, roughly 4.7 major publications for matched applicants against 4.2 for unmatched, are not in the SF Match report, which reports its own major-publication means as low in both groups and gives only presence-or-absence data.10 ⟳

The historical trend points one way: US allopathic senior match rate has softened from ~75% (2022) to ~72% (2025), reflecting rising competitiveness.56 The honest read: ophthalmology is reachable for a strong US-MD applicant, tough for DOs, and effectively closed to IMG seniors. And because everything runs early and separately, you need to commit and prepare earlier than for almost any other field.

Compensation — the robust version

Ophthalmology pay is one of the most misleading numbers in medicine if you read only the headline, because the specialty's real economics live in places salary surveys don't capture: surgery-center (ASC) ownership, cash-pay refractive and premium-lens revenue, and practice equity. A note on sources first, because they disagree sharply and for structural reasons: BLS captures W-2 wages only and excludes practice profit and ASC distributions, so it badly understates owners; SalaryDr's ophthalmology panel is 94 physicians and its retina panel 12; Medscape/Doximity are self-reported "total comp" surveys that under-capture large owner distributions; one figure below comes from FastRVU's own published planning model rather than from any survey, and is labeled that way; and crowdsourced sets (Physician Side Gigs, SalaryDr) have small samples and self-selection that can skew high.11

National number. Across the major surveys the "typical" total compensation sits in a band of roughly $410,000–$490,000: Medscape 2025 $409,000 (flat vs 2023), Medscape 2026 reported ~$464,000, Doximity 2025 $477,232, Physician Side Gigs ~$484,000. FastRVU's own 2026 planning model puts the median at $420,000, which sits inside that band but is a model rather than a survey.12 BLS (May 2025) shows just $304,650, the tell that owner income is missing.1113141516 A defensible "typical full-time" figure for 2025–26 is ~$450,000–$475,000 total comp, with the clear understanding that owners run well above it. ⟳

The spread (structure). The population tail is enormous and driven by ownership. Physician Side Gigs frames a practical range of ~$200,000 (part-time/employed low) to ~$1,500,000 (high), with top earners defined by private-practice ownership + a surgical subspecialty + 5+ years.17 SalaryDr's owner-heavy crowdsource (n≈94, treat as illustrative of the owner tail, not a population percentile) runs 10th pct $421k · 25th $505k · median $671k · 75th $850k · 90th $1.2M, out to a reported ~$3M.18 ⟳

Ownership matters more than seniority. New-grad pay isn't far off, and the step-change comes with making partner/owner, not with tenure. Physician Side Gigs: W-2 employees ~$476,000 vs. partners/owners ~$610,000 (≈28% higher).17 By setting, the ownership premium is even starker: academic ~$384,000 · hospital-employed ~$391,000 · self-employed ~$395,000 · group private practice (non-PE) ~$544,000 · PE-backed group ~$692,000 (the highest headline, but trading future equity/autonomy for near-term pay).1713 ⟳

ASC and surgery-center equity, the biggest income lever. Ophthalmology is the model specialty for physician-owned ASCs, because high-volume cataract and refractive surgery is elective, efficient, and outpatient. The facility-fee distributions to owner-physicians add six figures on top of professional-fee income and are not captured in most salary surveys:19

  • Net profit ~$100–$300 per case in a well-run center. A surgeon doing ~500 cataract cases/yr can add ~$50,000–$150,000/yr in ASC distributions on top of clinical pay.
  • Return on invested capital ~30%+; ASC profit margins 20–40%; rough viability floor ~700 cases/yr collectively.
  • Equity value on exit: ophthalmology practice/platform sales in 2025–26 command 12–20× EBITDA (platform) or 5–11× EBITDA (add-on), so a partnership stake is both an income stream and a potential one-time liquidity event.20 ⟳

Cash-pay refractive surgery and premium IOLs, the ancillary drivers. These out-of-pocket, non-insurance revenue streams are the other reason refractive/cataract-heavy owners out-earn survey averages (prices below are patient charges that drive practice profit, not physician take-home):2122

  • LASIK ~$2,632 per eye (range $1,500–$3,500), ~$5,264 for both eyes.
  • Premium IOL upgrades (patient out-of-pocket above Medicare-covered monofocal, per eye): toric $1,500–$3,500 · multifocal $2,000–$4,000+ · EDOF $2,000–$3,000 · light-adjustable lens up to ~$2,000, with bilateral out-of-pocket commonly $3,000–$10,000+.
  • Optical/dispensing and in-office testing add further margin, though no clean per-physician national figure is published. ⟳

Surgical volume is the engine. The same FastRVU 2026 model runs on a median of ~8,800 wRVU at ~$48/wRVU, and high-volume cataract surgeons drive both professional and facility income, and roughly half of ophthalmologists have base pay tied to RVUs/visit metrics.1213 ⟳

Geography. BLS (W-2 wage, understates owners) puts the top-paying states as Florida $391,060, Minnesota $373,600, Oregon $357,880, New York $353,390 and Iowa $352,380, on a series that publishes a mean for 34 states and rests on as few as 30 ophthalmologists in some of them.16 Aggregator/Medscape direction lists higher-nominal states as Washington/DC/New York/Massachusetts/Alaska and lower as Louisiana, Georgia, Arkansas, and West Virginia, but sources conflict (Florida shows "low" here yet tops the BLS list), so treat state rankings cautiously.14 This page previously carried the pattern usually reported for physician pay generally — that Midwest, Southern, rural and underserved markets pay more, and much more after cost of living. It is not asserted here, because ophthalmology is a field where the Bureau's own ordering now runs the other way, and the ophthalmology-specific evidence for the pattern was an all-specialty average standing in for a specialty figure. No clean ophthalmology-specific urban/rural dollar split exists in the primary surveys, and the delta is not established. ⟳

Subspecialty pay. Retina (vitreoretinal) is the top earner, at ~$699,000 average per Physician Side Gigs (≈37% above the specialty average); oculoplastics also very high; glaucoma/cornea mid; pediatrics lowest (less surgical-fee volume). Crowdsource subspecialty cells are tiny (some SalaryDr means inflate to $600k–$1.4M), so treat the ordering, retina and oculoplastics highest, then glaucoma and cornea, then pediatrics lowest, as more reliable than any single number, and note that a high-volume cataract/refractive owner can match retina via volume + ASC + cash-pay.171823 ⟳

The trend that colors all of it. Comp was flat 2023→2024 (~$409k) then reportedly jumped ~9% to ~$464k in the 2026 report, a rise well above the ~3% physician-wide average and one that reaches this site through a secondary summary rather than the report itself. Meanwhile private-equity consolidation keeps maturing: many vision-practice PE assets are now past the typical 5-year hold, pointing to an exit/recap wave.1420 Income is increasingly driven by procedural volume + surgery-center ownership + cash-pay activity rather than experience alone, and a persistent gender gap remains (male ~$549k against female ~$459k, ≈20%, per Physician Side Gigs).17 Despite the strong pay, only ~28% (Medscape 2025) felt fairly compensated, a reminder that headline numbers and felt adequacy diverge.14 ⟳

Lifestyle & the ROAD bargain

The single most-cited pro of ophthalmology is that it delivers a surgeon's craft and income with a genuinely controllable schedule, the reason it anchors the ROAD lifestyle group.1 Practicing ophthalmologists average ~46 hours/week (SalaryDr survey, n≈114), below most surgical fields and near the low end of medicine.24 Surgery is elective and self-scheduled, clinic is predictable, call is light, and there's almost no inpatient service. You can plan your life around it in a way surgeons in most other fields cannot.1

The honest counterweight is scope and monotony rather than grueling hours. You master one organ; high-volume cataract practices can become repetitive; and the "ophthalmology lifestyle" is really a private-practice lifestyle: SalaryDr's panel of 114 ophthalmologists rates private-practice satisfaction 4.6/5 against academic 2.8/5.24 Retina and oculoplastics also carry meaningfully more urgent call than a general/cataract practice.1

Lifestyle rating: 5/5. High schedule predictability and high control (elective surgery, minimal call, outpatient), with the caveat that the best version is a private/ownership version.

Wellbeing — the part that's genuinely reassuring

Burnout: among the lowest in medicine. The AMA's 2025 Organizational Biopsy, free, current and primary, puts ophthalmology at 25.8% against a 41.9% all-physician average, second-lowest of the fifteen specialties it breaks out and sixteen points under the baseline.25 ⟳ Medscape reads the field the same direction on its own scale, at ~39% against that survey's 49% all-physician average in the 2024 edition and ~40% against ~47% in 2022.2526 ⟳ Reported clinical depression was ~10% against ~24% for the general physician pool, less than half the average.25 ⟳

Happiness & satisfaction: consistently top-tier. Ophthalmology is a durable top-ten "happiest" specialty, 6th in Medscape's 2025 Mental Health & Well-Being report, with ~84% agreeing physicians in their specialty can be happy and well-balanced, and it sits among the happier fields outside work (~62%, Medscape 2024).2728 Self-reported "would choose it again" is one of the strongest in all of medicine: SalaryDr respondents rate career satisfaction 4.2/5 and ~95% would choose ophthalmology again.24 ⟳

Career longevity is a real strength. This is where ophthalmology quietly outperforms most surgical fields: microsurgery under an operating microscope is physically sustainable into later career, with no heavy standing, retracting, or long open cases like general or orthopedic surgery, and cataract volume scales gracefully. Ophthalmologists commonly practice into their 60s–70s, tapering surgical load while keeping clinic.1

Who's in the field (demographics)

  • Women: 28% of practicing ophthalmologists on AAMC's 2022 data, below the 38% all-physician share of the same year, but the pipeline is more balanced: 42.6% of residents in AY2024-25 and ~35% of applicants, though a small (~2.5%) decline in female residents was reported 2011→2019.2930 Leadership lags the pipeline: ~29.6% of academic faculty, ~28% of program directors, and only ~13% of full professors are women.30 ⟳
  • DO: a small minority that matches at markedly lower rates: DO seniors 34%, DO graduates 36% (2025 SF Match), down from ~45% in 2022. Ophthalmology is comparatively DO-unfriendly relative to fields like EM or FM.65 ⟳
  • IMG: ophthalmology is one of the least IMG-accessible specialties, with IMGs filling only ~2–3% of positions; in 2025 international graduates matched at 21% and made up just 2% of matched (11/524), while international seniors matched at 0%.63 ⟳
  • URiM: in 2025, 18% of rank-list applicants and 15% of matched were underrepresented in medicine.6 ⟳

Culture, personality & the online stereotypes

Who gravitates here: precise, detail-oriented people with excellent fine-motor dexterity and comfort working at high magnification through a microscope; those drawn to optics, imaging technology, and the physics of the eye; and people who explicitly want a lifestyle-compatible surgical career, who like both clinic and the OR. Many are also pragmatic and business-minded, because the specialty genuinely rewards owning your practice and your surgery center. As always, plenty of people in the field do not fit any single mold.1

The stereotypes. Community caricatures rather than facts, each with an unfair edge:

  • "Ophthalmologists aren't real doctors. They're just eyeball people." Reality: they complete medical school plus a full surgical residency and operate on one of the body's most delicate structures, and the retinal exam catches systemic disease (diabetes, hypertension, tumors, raised ICP) before other specialties do.1
  • "It's lifestyle-plus-money, medicine on easy mode." Reality: the lifestyle is real, but so is the microsurgical skill ceiling of sub-millimeter maneuvers where a tremor causes permanent blindness. The stakes are sight.1
  • "They gave up broad medicine to master one organ." Partly true, framed unfairly: narrow scope is a genuine trade-off, but the depth within it is immense, and sight-saving work is not a lesser calling.1

What people say online (synthesized and paraphrased, not quotes): Across trainee and physician forums the tone is broadly positive and protective of the field's lifestyle-plus-craft identity; people who match are usually thrilled. Two tensions dominate serious discussion. First, the optometry scope-of-practice battle, treated as the defining professional-political fight. Optometrists (OD, not MD) are lobbying state by state to expand into laser procedures, in-office surgeries, injections, and even eyelid surgery with far less training, which ophthalmologists frame as a patient-safety line; sentiment ranges from alarmed to fatalistic as scope keeps expanding in some states. Second, private-equity consolidation, a long-running anxiety that PE roll-ups erode autonomy, impose production quotas and short visit caps, and change the ownership calculus for new grads, with older independent owners wary and some younger docs seeing PE as administrative relief and a liquidity option.3132

Voices from the field. Paraphrased from public writing, with links to the originals:

  • An ophthalmologist writing for the AAO's Young Ophthalmologists lays out the subspecialty landscape and stresses that fellowship is not mandatory, and that comprehensive and general ophthalmologists remain highly valued.2
  • Lauren Lee, in Ophthalmology Management, frames the core early-career choice: PE offers administrative relief, negotiating leverage, and predictable schedules but costs autonomy and can pressure clinical decisions, while independent practice keeps control and community ties at the cost of the full admin burden.33
  • An ophthalmologist on KevinMD argues that accelerating PE acquisition in ophthalmology correlates with lower quality and higher costs, pushes production quotas, and, by making physicians less available, indirectly fuels non-physician scope expansion.34
  • AMA scope-of-practice reporting documents the optometry surgical-privilege fight: California's 2022 bill (lasers plus scalpel eyelid surgery after 32 hours of training) vetoed by Gov. Newsom, and West Virginia's eyelid-surgery rule voided by a court in Nov. 2025, illustrating the ~12,000–16,000 clinical-hour training gap ophthalmologists cite.35

Why people choose it / why people leave

Why choose it: a surgeon's craft and income with a genuinely controllable, low-call, mostly-outpatient schedule · very high satisfaction (~95% would re-choose, on SalaryDr's panel of 114) and low burnout/depression · immediate, visible, life-changing outcomes (restoring sight) · a technology-rich field (optics, lasers, OCT, constant device innovation) · practice and ASC ownership as a strong wealth-building path · excellent career longevity into the 60s–70s · no required fellowship to practice comprehensively.

Why leave or avoid it: narrow scope, since you master one organ, which can feel confining if you crave systemic breadth · cataract-heavy practices can become repetitive · optometry scope creep threatens procedure volume in some states · PE consolidation can erode autonomy for employed/bought-out physicians and may limit the ownership path that makes the economics special · long-term reimbursement pressure on high-volume procedures · academic satisfaction runs notably below private practice · and the gate itself: a very competitive, logistically distinct SF Match with little room for IMGs and tough odds for DOs.

Best fit if: you have excellent fine-motor precision and patience for microscope work · you want surgery and a real life outside medicine · you like optics/technology and procedural efficiency · you're entrepreneurial about owning a practice/ASC · you're content going deep on one organ.

Not for you if: you want broad, whole-body medicine or long-term continuity across many systems · you dislike high-volume repetitive procedures · you want a large inpatient/acute footprint · you're unwilling to run the SF Match gauntlet · or you'd resent the optometry/PE political headwinds.

The FLI angle — Ophthalmology for first-gen, low-income & immigrant students

Ophthalmology is one of medicine's strongest wealth-and-stability plays for first-gen, low-income, and immigrant students, if you can get in. The catch is that "if" is bigger here than in almost any other field.

Where ophthalmology fits FLI realities well:

  • Elite risk-adjusted lifestyle and earnings. Top-tier compensation with low burnout, low depression, high satisfaction, and a controllable schedule that protects family and other obligations. Because surgery is efficient and elective, income per hour is excellent, and you're not trading your whole life for the paycheck.124
  • The wealth lever is real and specific: ownership. ASC (surgery-center) ownership and practice equity are the accelerators. An ophthalmologist who owns a stake in where they operate captures the facility fee rather than only the professional fee, and a partnership stake can become a sizable one-time liquidity event on sale.1920 For a first-gen physician building generational wealth from zero, this is one of medicine's clearest business paths (comparable to GI/derm ownership models).
  • Career longevity protects the investment. A physically sustainable microsurgical career into the 60s–70s means more earning years and less forced early exit than punishing surgical fields.1

Risks to name honestly:

  • The gate is the hard part. Ophthalmology is very competitive and runs through the separate, earlier SF Match, with its own timeline, its own logistics, fewer safety nets, and an application that needs a near-top Step 2 CK, research, aligned letters, and away/audition exposure.16 DO applicants match at much lower rates and IMG seniors essentially don't match, so DO and immigrant-graduate students should weigh those odds soberly.63 Crucially, because the field is small and the timeline compressed, FLI students without built-in mentorship must find ophthalmology guidance early, because home-program and research exposure matter a lot, and this is not a field to "back into" late.
  • The wealth lever assumes you can still own. PE consolidation may narrow the independent-ownership path that makes the economics special. If you end up employed or bought out, you capture the pay but not the equity upside.3220
  • Scope and scope-creep. If you value breadth, the lifestyle won't compensate for a single-organ career, and optometry scope battles could compress the procedure moat in some states over a career.35

Bottom line for FLI: elite risk-adjusted lifestyle and earnings, with a genuine ownership path to generational wealth, sitting behind a competitive and logistically distinct gate. Worth targeting early and deliberately if it fits you; not a field to back into late.

Subspecialties & fellowships (mostly optional)

Most ophthalmology fellowships are non-ACGME, overseen by the AUPO Fellowship Compliance Committee (FCC) and matched, again, through SF Match rather than the NRMP. The word doing the work there is most: ACGME accredits four ophthalmic plastic and reconstructive surgery programs, holding five fellows in AY2024-25, and no other ophthalmology subspecialty has a row in its data book.36 ⟳ None is required to practice: comprehensive/general ophthalmology (cataract-centered, broad clinic + surgery) remains a highly valued, lifestyle-friendly path.237

  • Vitreoretinal / Retina (medical + surgical). The most fellowship spots (~130s) and the highest-earning subspecialty, with the most urgent call; treats detachments, diabetic eye disease, and macular degeneration. Surgical retina is a 2-year fellowship.3723
  • Cornea & External Disease / Refractive. ~90 spots, ~1 yr; corneal transplants, LASIK/refractive surgery, ocular-surface disease, complex cataract.37
  • Glaucoma. ~70 spots, ~1 yr; medical/laser/surgical management of optic-nerve damage from eye pressure, with a growing MIGS toolkit.37
  • Oculoplastics (via ASOPRS). ~20–25 spots across 15–17 programs, ~2 yr; eyelid, orbit, and lacrimal surgery plus cosmetic/reconstructive periorbital work; among the highest-paid. See the oculoplastic surgery profile for the applicant-side numbers.3723
  • Pediatric Ophthalmology & Strabismus. ~60 spots, ~1 yr; childhood eye disease and eye-muscle/alignment surgery; lower-paying, high-relationship.3723
  • Neuro-ophthalmology. ~20 spots, ~1 yr; vision problems from brain/nerve disease; largely cognitive/diagnostic, less procedural (matched via NANOS).377
  • Uveitis / Ocular Immunology. Few spots, ~1 yr; intraocular inflammatory and autoimmune disease, often with systemic overlap.37
  • Ocular Oncology / Pathology. Small, niche; tumors of the eye and orbit; ocular pathology is largely lab/diagnostic.37

(Fellowship durations above are typical field norms; the AUPO FCC confirms the 9-subspecialty list and SF Match use but does not publish standardized durations.) ⟳

Fun facts

  • Cataract surgery is the most commonly performed surgical procedure in the US across all of medicine, millions per year, and among the most cost-effective interventions in all of health care.1
  • The eye is the only place a physician can directly and non-invasively view blood vessels and a cranial nerve (the optic nerve) in a living person, which makes the retinal exam a genuine window into systemic disease.1
  • Ophthalmology runs its own separate match (SF Match) on an earlier timeline than the NRMP, so you interview and match roughly a year ahead of most classmates.35
  • Ophthalmology applicants post the highest average Step 2 CK score of any specialty (258 among matched US seniors), higher than any field has historically recorded.61
  • Modern intraocular lenses can correct distance, intermediate, and near vision (multifocal/EDOF) and even astigmatism, so cataract surgery increasingly doubles as refractive surgery.1
  • Much of the "surgery" happens in a surgeon-owned ASC rather than a hospital OR, a structural reason the lifestyle and the economics are both favorable.1

Sources

Footnotes

  1. Ophthalmology lifestyle, wellbeing, culture, procedures, career longevity, ROAD framing, fun facts, and FLI synthesis. Compiled briefing drawing on Medscape lifestyle/mental-health reports, SalaryDr, AAO, KevinMD, Ophthalmology Management, and paraphrased Reddit/SDN sentiment (2022–2026). SalaryDr Ophthalmology Work-Life Balance (https://www.salarydr.com/specialty-lifestyle/ophthalmology); Med School Insiders, "Did Ophthalmology Just Become the Most Competitive Specialty?" (2024–25) (https://medschoolinsiders.com/pre-med/ophthalmology-competitiveness/). SalaryDr panel size: n=116. A self-selected physician panel; the n is disclosed here because it is what the figure rests on. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14 ↩15 ↩16 ↩17 ↩18 ↩19 ↩20 ↩21 ↩22 ↩23 ↩24

  2. David W. Parke III, MD — AAO Young Ophthalmologists, "In Pursuit of Fellowship" (subspecialty landscape; fellowship not mandatory) (n.d., current 2026). https://www.aao.org/young-ophthalmologists/yo-info/article/in-pursuit-of-fellowship ↩ ↩2 ↩3

  3. Ophthalmology training structure, the separate SF Match, separate PGY-1, integrated/joint rule (ACGME eff. July 1, 2021), application volume, and IMG ~3% of positions. AAO, "Residency Match Basics" (accessed 2026). https://www.aao.org/medical-students/residency-match-basics ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7

  4. SF Match / AUPO Ophthalmology Timetable and Central Application Service (2025–26 cycle). https://sfmatch.org/specialty/ophthalmology-residency/Timetable ↩

  5. The DO, "What future ophthalmologists need to know about the SF Match" — results ~Feb 1 (weeks before NRMP); 2022 SF Match data anchor. https://thedo.osteopathic.org/columns/what-future-ophthalmologists-need-to-know-about-the-sf-match/ ↩ ↩2 ↩3 ↩4

  6. 2025 Ophthalmology Residency Match General Report, AUPO/SF Match (2025) — programs (123: 56 integrated/67 joint), 525 positions/524 filled/99.8% fill, 812 rank-list applicants, 65% overall match, category match rates, URiM 18%/15%. https://aupo-24-prod-backend.parallelpublicworks.com/sites/default/files/2025-11/2025-SFMatch-Results-Explanations.pdf ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11

  7. PGY-2–4 ACGME accreditation; FREIDA/AMA ophthalmology specialty details; neuro-ophthalmology via NANOS. https://freida.ama-assn.org/specialty/ophthalmology ; https://www.acgme.org ; https://www.nanosweb.org/fellowships/ ↩ ↩2

  8. American Board of Ophthalmology (ABO) certification — residency attestation, Written Qualifying Exam, Oral Exam; 10-year certificate + Continuing Certification. ABO Board Certification FAQ (accessed 2026) (https://www.abop.org/exams); AAO, "What is the ABO?" (https://www.aao.org/young-ophthalmologists/yo-info/article/what-is-the-abo-preparing-for-oral-boards). ↩

  9. Ophthalmology's competitiveness rivaling dermatology/plastics. Med School Insiders (2024–25). https://medschoolinsiders.com/pre-med/ophthalmology-competitiveness/ ↩

  10. Step 2 CK displacing Step 1 as the screening metric: JSE, "Is USMLE Step 2 CK the New Step 1 for Ophthalmology…" (2025) (https://www.sciencedirect.com/science/article/abs/pii/S1931720425004325). The publication pair, ≈4.7 major publications matched against ≈4.2 unmatched, comes from a Rezumab match-statistics summary (2026) (https://rezumab.app/blog/ophthalmology-match-statistics-2026) and has no located primary: the AUPO/SF Match General Report at 6 treats major publications as a mean it describes as low in both groups plus presence-or-absence tables, and prints no such pair, and the JSE analysis is paywalled at ScienceDirect. It is stated on this page as a figure "often quoted" rather than as a measurement. Corrected 2026-08-17: this footnote sourced the Step 2 CK pair (258/245) and the 27% AOA share to Rezumab "citing NRMP Charting Outcomes 2024." NRMP Charting Outcomes 2024 contains no ophthalmology table and the string "ophthalmolog" does not appear in it once, because ophthalmology does not match through the NRMP — which is this page's own opening argument. Rezumab's attribution is wrong and the page repeated it. Both figures are published by the correct primary, the 2025 AUPO/SF Match General Report already cited at 6: "matched US Seniors had an average USMLE Step 2 CK score of 258, while unmatched US Seniors had 245" and "27% of matched applicants had an AOA status of 'Elected.'" Both are now attributed there. ⟳ ↩

  11. "What each source measures" (BLS wage-only understates owners; Medscape/Doximity self-report; aggregator planning models are not surveys; crowdsource small-sample skew). Ophthalmology compensation briefing (July 2026), aggregating the sources below. ↩ ↩2

  12. FastRVU, "Ophthalmology RVU calculator," an aggregator's own published planning model rather than a benchmark survey. Its own sentence is: "Calculate ophthalmology RVUs and compensation using a 2026 benchmark model: 8,800 median annual wRVUs, $48 per wRVU, and about $420K median clinical compensation." The page also states, in its disclaimers, "FastRVU educational product. Not produced by MGMA, AMGA, SullivanCotter, CMS, or AMA" and "FastRVU does not own or reproduce restricted benchmark datasets; confirm the survey year, specialty scope, license, and methodology before using any benchmark." https://fastrvu.com/specialties/ophthalmology ⟳ Corrected 2026-08-17: the three numbers are exact against that page, and the attribution was not. This page presented them as "MGMA 2026 Provider Compensation," twice in the body and here, with an mgma.com link labeled as the primary, for figures the source says are not MGMA's. The MGMA label is gone and the figures are not re-quoted more accurately, because a more accurate quotation of an aggregator is not the repair the standard asks for; the word MGMA is what makes a reader trust a compensation number. This host sits outside every tier this site accepts for a compensation figure, and re-researching the $420,000 from an admissible source is still open. Corrected 2026-08-17: figures of this kind stay with the host named rather than being removed, so the body now says FastRVU by name in all three places these numbers are used — the source note, the national-number paragraph and the surgical-volume paragraph — instead of "an aggregator." A reader meeting the $420,000 now learns whose model it is at the point they read it. ↩ ↩2

  13. Medscape Ophthalmologist Compensation Report 2025 (2024 data) — ~$409,000 avg (flat vs 2023); academic/employed/self-employed splits; ~half have RVU-linked base; ~28% feel fairly compensated. Via Physicians Thrive (https://physiciansthrive.com/physician-compensation/ophthalmologist-salary/) and Becker's ASC (https://www.beckersasc.com/ophthalmology/ophthalmologist-pay-remains-flat-10-new-compensation-stats/). ⟳ ↩ ↩2 ↩3

  14. Medscape Ophthalmologist Compensation Report 2026 — ~$464,000 avg (~9% YoY, via a secondary summary); state direction and trend framing. Via Nuaxia (https://www.nuaxia.com/post/medscape-ophthalmologist-compensation-report-2026). ⟳ ↩ ↩2 ↩3 ↩4

  15. Doximity 2025 Physician Compensation Report (2024 data) — ophthalmology avg $477,232 (~20th among specialties); women −$120,917 adjusted overall. https://www.doximity.com/reports/physician-compensation-report/2025 ↩

  16. BLS OEWS May 2025, Ophthalmologists Except Pediatric (SOC 29-1241): mean $304,650 ($146.47/hr) on employment of 8,950, median $300,080, 90th percentile $489,710, all W-2 wage and so understating owners. Top-paying states Florida $391,060, Minnesota $373,600, Oregon $357,880, New York $353,390 and Iowa $352,380. US Bureau of Labor Statistics, Occupational Employment and Wages — May 2025, Table 1 with the state cross-industry estimates (https://www.bls.gov/news.release/archives/ocwage_05152026.htm; state file at https://www.bls.gov/oes/special-requests/oesm25st.zip). Thirty-four states carry a published mean, several on fewer than a hundred ophthalmologists, with relative standard errors above 20% at both ends. Updated 2026-08-18: this note carried May 2023 figures and the mean has since fallen to $304,650. The state ordering changed more than the mean did. Iowa led the May 2023 list at $430,910 and now sits fifth at $352,380 on 90 ophthalmologists, and South Carolina and Illinois have left the top four, so the reading this page drew from that list, that its leader was low-population and underserved, no longer describes the data and has been removed. ↩ ↩2

  17. Physician Side Gigs, Average Ophthalmologist Salary (2023–24 data) — ~$484,000 avg / ~$509,000 full-time; W-2 $476k vs partner/owner $610k (≈28%); setting splits (group non-PE $544k, PE-backed $692k); ~$200k–$1.5M range; gender gap ($549k vs $459k); retina ~$699k. https://www.physiciansidegigs.com/average-ophthalmologist-salary ↩ ↩2 ↩3 ↩4 ↩5

  18. SalaryDr Ophthalmology (updated July 2026, n≈94, owner-heavy crowdsource) — percentile spread 10th $421k / 25th $505k / median $671k / 75th $850k / 90th $1.2M to ~$3M; ~95% would choose again. Treat tail as owner-upside illustration, not population percentile. https://www.salarydr.com/specialty/ophthalmology ⟳ ↩ ↩2

  19. ASC / surgery-center economics — net profit ~$100–$300/case, +$50k–$150k/yr at ~500 cataract cases, ROIC ~30%+, margins 20–40%, ~700-case viability floor. Ophthalmology Management, "The ASC Is Still the Place to Be" (~2016 figures, likely conservative against current facility-fee reimbursement). https://ophthalmologymanagement.com/issues/2016/october/the-asc-is-still-the-place-to-be/ ⟳ ↩ ↩2

  20. Practice/ASC equity value & PE trend — 12–20× EBITDA (platform) / 5–11× (add-on); vision PE assets past 5-yr hold → exit/recap wave. FOCUS Investment Banking (2026). https://focusbankers.com/ophthalmology-ebitda-multiple/ ⟳ ↩ ↩2 ↩3 ↩4

  21. LASIK ~$2,632/eye ($1,500–$3,500), ~$5,264 both eyes. NVISION (2025). https://www.nvisioncenters.com/lasik-cost/ ⟳ ↩

  22. Premium IOL out-of-pocket upgrades (toric/multifocal/EDOF/light-adjustable), bilateral $3,000–$10,000+. Surgery Cost Guide (2026). https://surgerycostguide.com/blog/premium-iol-cataract-surgery-cost.html ⟳ ↩

  23. Subspecialty pay ordering (retina & oculoplastics highest → glaucoma/cornea mid → pediatrics lowest) — retina ~$699k (Physician Side Gigs); SalaryDr subspecialty means come from very small samples. https://www.physiciansidegigs.com/average-ophthalmologist-salary ; https://www.salarydr.com/specialty/ophthalmology ; https://www.salarydr.com/specialty/ophthalmology/retina ⟳ SalaryDr panel sizes: n=12, n=94. A self-selected physician panel; the n is disclosed here because it is what the figure rests on. ↩ ↩2 ↩3 ↩4

  24. SalaryDr Ophthalmology Work-Life Balance (2024–25 survey, n≈114) — ~46 hrs/week; career satisfaction 4.2/5; ~95% would choose again; private practice 4.6/5 vs academic 2.8/5 satisfaction. https://www.salarydr.com/specialty-lifestyle/ophthalmology ⟳ ↩ ↩2 ↩3 ↩4

  25. Burnout. Corrected 2026-08-17: the dashboard, the body and the wellbeing figure now lead with the AMA row rather than Medscape's, and the Medscape reading follows against its own baseline. AMA is the instrument this page prefers wherever it publishes a row, because it is free, primary and current, and ophthalmology is one of the roughly fifteen the Organizational Biopsy breaks out. AMA Organizational Biopsy 2025 — nearly 19,000 physician responses across 106 health systems in 38 states — puts Ophthalmology at 25.8% against a 41.9% all-physician average, second-lowest of the rows it names, https://www.ama-assn.org/practice-management/physician-health/these-9-physician-specialties-report-highest-burnout-rates. It is primary where Medscape reaches this page through relays, and its baseline sits seven points below Medscape's 49% — the two never belong in the same sentence, and a cross-specialty rank must name which survey it comes from. The Medscape reading kept beside it: Medscape Ophthalmologist Lifestyle, Happiness & Burnout Report 2022 — burnout ~40% against ~47% overall, depression ~10% against ~24%, https://www.medscape.com/viewarticle/968780. ⟳ ↩ ↩2 ↩3

  26. Cross-specialty burnout — Ophthalmology ~39%, among the lowest (Medscape 2024). Medscape 2024 via Becker's ASC. https://www.beckersasc.com/asc-news/the-20-physician-specialties-with-the-highest-lowest-burnout-rates/ ⟳ ↩

  27. Medscape Physician Mental Health & Well-Being Report 2025 — ophthalmology 6th "happiest," ~84% say specialty can be happy/well-balanced; durable top-ten pattern. Via Healthgrades. https://resources.healthgrades.com/pro/happiest-physicians-by-specialty ; https://resources.healthgrades.com/pro/8-fast-facts-about-burnout-among-ophthalmologists ⟳ ↩

  28. Happiness outside work — Ophthalmology ~62% (Medscape 2024). Medscape 2024 lifestyle via HCN. ⟳ ↩

  29. Women practicing, 28%. AAMC, "Women are changing the face of medicine in America" (2022 data), https://www.aamc.org/news/women-are-changing-face-medicine-america , which puts ophthalmology at 28% and the all-physician share at 38% for the same year. Swept 2026-08-17: this page carried "~25–26%" in the dashboard and in the demographics bullet, on the strength of two relays of the AAMC data — YoungMD Connect (https://youngmdconnect.com/articles/2023-june/gender-based-differences-in-ophthalmology-a-review) and Aquwa et al.'s ~26.1% of AAO members, a different denominator, via Ophthalmology Times (https://www.ophthalmologytimes.com/view/where-women-stand-a-progress-report-on-gender-equity-in-ophthalmology). AAMC's own page says 28%. The membership share and the workforce share are two facts, not one, which is how a relay of the second came to stand in for the first. Every other profile in this family had already moved to 28% and cited AAMC directly; this one, the parent they all point at, had not, so the site disagreed with itself in one direction on six pages and the other on one. AAMC is the primary and 28% is the figure. ⟳ ↩

  30. Women residents, 42.6%, and the applicant and leadership shares. Residents: ACGME, Data Resource Book, Academic Year 2024-2025, Table C.21, https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf , which gives ophthalmology 762 of 1,790 residents female, 42.6%. Applicants (35.3%) and leadership (faculty 29.6%, program directors 28%, full professors 13%): Aquwa et al., JAMA Ophthalmology (2021); Kloosterboer et al., Am J Ophthalmol (2020); Camacci et al., JAMA Ophthalmol (2020), via Ophthalmology Times and YoungMD Connect (2023). Swept 2026-08-17: the resident figure was a ~40–44% band from a 2021 paper. ACGME publishes the count directly and it is 42.6%, inside that band, which is what every other profile in this family already carried. ⟳ ↩ ↩2

  31. Synthesized online sentiment (r/ophthalmology, r/medicalschool, SDN) — optometry scope battles and PE consolidation as the two dominant tensions; paraphrased, no quotes. Ophthalmology lifestyle/culture briefing (2026). ↩

  32. AAO, "Private Equity and Ophthalmology" (consolidation overview). https://www.aao.org/eyenet/article/private-equity-and-ophthalmology ↩ ↩2

  33. Lauren Lee — Ophthalmology Management, "Private Equity or Private Practice?" (Jul/Aug 2025). https://www.ophthalmologymanagement.com/issues/2025/julyaugust/private-equity-or-private-practice/ ↩

  34. John C. Hagan III, MD — KevinMD, "Physician shortage and private equity: the ruin of U.S. health care" (Dec 2025). https://kevinmd.com/2025/12/physician-shortage-and-private-equity-the-ruin-of-u-s-health-care.html ↩

  35. AMA scope-of-practice reporting — optometry surgical-privilege fight (CA 2022 veto; WV 2025 court voiding); ~12,000–16,000 clinical-hour training gap. AMA (2025) (https://www.ama-assn.org/practice-management/scope-practice/court-voids-rule-letting-optometrists-do-eyelid-surgery); optometry side, Review of Optometry (2025) (https://www.reviewofoptometry.com/article/two-scope-wins-secured-in-2025-several-on-deck-for-2026). ↩ ↩2

  36. The one accredited ophthalmology fellowship. ACGME, Data Resource Book, Academic Year 2024-2025, https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf , carries a single subspecialty row under Ophthalmology — ophthalmic plastic and reconstructive surgery, 4 accredited programs and 5 fellows — against 128 ophthalmology residency programs and 1,790 residents, and the book counts accredited programs. Swept 2026-08-17: four profiles in this family stated the non-ACGME status as a claim about ophthalmology fellowships as a class, and one of them was the oculoplastic surgery profile, the subspecialty the row is about. This page's "most" was already right; the exception is named here so the hedge is checkable rather than a hedge. The larger ASOPRS two-year fellowship route runs outside accreditation and is what most oculoplastic surgeons complete, so both structures are real and neither replaces the other. ⟳ ↩

  37. Fellowship subspecialty list, spot counts, and durations — AUPO Fellowship Compliance Committee (9 subspecialties, SF Match) (https://aupofcc.org/fellowship-programs-for-residents); spot counts per AAO "In Pursuit of Fellowship" (durations are typical field norms). Corrected 2026-08-13: the oculoplastics row previously read ~40 spots, roughly double the 20–25 that this site's own oculoplastic-surgery profile reports from applicant guidance. https://www.aao.org/young-ophthalmologists/yo-info/article/in-pursuit-of-fellowship ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9

Researched with AI assistance and reviewed by hand. How this site is made